Lv2
110 积分 2024-08-02 加入
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
1个月前
已完结
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
1个月前
已完结
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug Conjugates
1个月前
已完结
Molecular landmarks of tumor hypoxia across cancer types
1个月前
已完结
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy
1个月前
已完结
Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer
2个月前
已完结
Maintenance strategy in metastatic colorectal cancer: A systematic review
2个月前
已完结
Cetuximab in Combination With Capecitabine, Irinotecan, and Radiotherapy for Patients With Locally Advanced Rectal Cancer: Results of a Phase II MARGIT Trial
6个月前
已完结
Preoperative Chemoradiation With Cetuximab, Irinotecan, and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: A Multicenter Phase II Study
6个月前
已完结
Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study
6个月前
已完结
皖公网安备34019202002308
